About Fugent, LLC
Fugent, LLC, based in Madison Wisconsin, is a biotech company with focus on development, production, and commercialization of biotechnology reagents.
The company was founded (by V. Gurevich) in 1995 and since then has become a leader in the development of breakthrough transfection technology. FuGENE® 6 and FuGENE® HD are referenced in more than ten thousand peer-reviewed publications.
Fugent, LLC has a portfolio of several innovative products currently in various stages of development.
Tel: (608) 345-7558
Fax: (608) 241-7775
910 Shasta Dr.
Madison, WI 53704
Fugent, LLC Transfection Reagent Products
FuGENE® 6, one of Fugent’s premier products, is a multi-component lipid-based transfection reagent. FuGENE® 6 Transfection Reagent allows for the efficient delivery of DNA vectors from very large plasmids to oligonucleotides and nucleotides into a broad range of cell types with extremely low cytotoxicity. FuGENE® 6 saves time and resources because it minimizes reagent preparation, media changes, and optimization. It also eliminates the side effects of toxicity while providing high transfection efficiency, which leads to successful transfection of more than 800 cell lines.
FuGENE® 6 transfection reagent can be used for the study of promoter regulation, differential gene expression, and cell-based protein and viruses production and for other applications in functional genomics, proteomics and cellular analysis.
FuGENE® HD is the next generation multi-component transfection reagent designed for the transfection of eukaryotic cells, including insect cells. FuGENE® HD Transfection Reagent is free of animal-derived components. It interacts with nucleic acids and promotes efficient transfer across cellular membranes with minimal physiological and morphological cell changes.
FuGENE® HD combines minimal cytotoxicity with excellent transfection efficiency in many cell lines that have not been transfected well by other reagents. In addition, FuGENE® HD has produced excellent results in both the presence and absence of serum. FuGENE® HD has an exclusive ability to perform transfection in 100% serum, thus closely mimicking transfection in in vivo conditions. FuGENE® HD transfection reagent also provides quicker results in less time with its simple, consistent, two-step protocol applicable across a wide range of cell types.